Selenium is critical for cancer-signaling gene expression but not cell proliferation in human colon Caco-2 cells

Area of Science:

• Nutritional biochemistry
• Cancer biology
• Molecular genetics

Background:

• Selenium (Se) is recognized for its essential role in cell growth and potential anticarcinogenic properties.
• Certain cancer cells exhibit a survival advantage in Se-deficient conditions, prompting investigation into Se's molecular anticancer mechanisms.
• Understanding Se's effects at nutritional doses is crucial for cancer prevention and therapy.

Purpose of the Study:

• To investigate the molecular basis of Selenium's (Se) anticancer effects at nutritional doses in cultured colon Caco-2 cells.
• To generate Se-deficient Caco-2 cells and compare their characteristics with Se-supplemented cells.
• To analyze differential gene expression related to cancer signaling pathways in response to Se status.

Main Methods:

• Generation of Se-deficient Caco-2 cells by gradual serum reduction in culture media.
• Measurement of glutathione peroxidase (GPx) activity in Se-deficient and Se-supplemented cells.
• Utilizing a cancer signal pathway-specific array assay and real-time PCR to analyze gene expression.

Main Results:

• Se-deficient Caco-2 cells showed significantly lower GPx activity compared to Se-supplemented cells.
• No significant differences in cell growth or cell cycle progression were observed between Se-deficient and Se-supplemented cells.
• Se supplementation modulated the expression of key cancer-related genes, increasing humoral defense (A2M) and tumor suppressor genes (IGFBP3, HHIP), while decreasing pro-inflammatory genes (CXCL9, HSPB2).

Conclusions:

• Colon Caco-2 cells demonstrate resistance to Se deprivation at the cellular growth level.
• Selenium exerts potential anticancer properties by altering the expression of specific cancer signaling genes.
• Modulation of humoral defense, tumor suppressor, and pro-inflammatory genes by Se suggests a role in its anticarcinogenic effects.